Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children

Surgery

Volumn 140, Issue 6, 2006, Pages 1035-1042

  Antonelli, Alessandro ^a   Miccoli, Paolo ^a   Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Grosso, Mariano ^a   Boni, Giuseppe ^a   Berti, Piero ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK; PEDIATRICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

ADOLESCENT; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; NECK; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; WHOLE BODY IMAGING;

EID: 33845572937     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.08.006     Document Type: Article

References (25)

1. Pacini F., Lari R., Mazzeo S., Grasso L., Taddei D., and Pinchera A. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 23 (1985) 405-411
2. Ladenson P.W., Braverman L.E., Mazzaferri E.L., Bruker-Davis F., Cooper D.S., Garber J.R., et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337 (1997) 888-896
3. Mazzaferri E.L., and Kloos R.T. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 87 (2002) 1490-1498
4. Wartofsky L. Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic 131-I scanning. J Clin Endocrinol Metab 87 (2002) 1486-1489
5. Robbins R.J., Chon J.T., Fleisher M., Larson S.M., and Tuttle R.M. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?. J Clin Endocrinol Metab 87 (2002) 3242-3247
6. Antonelli A., Miccoli P., Ferdeghini M., Di Coscio G., Alberti B., Iacconi P., et al. Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 5 (1995) 25-29
7. Pacini F., Molinaro E., Castagna M.G., Agate L., Elisei R., Ceccarelli C., et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88 (2003) 3668-3673
8. Kloos R.T., and Mazzaferri E.L. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90 (2005) 5047-5057
9. Antonelli A., Miccoli P., Fallahi P., Grosso M., Nesti C., Spinelli C., et al. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 13 (2003) 479-484
10. DeGroot L.J., and Stanbury J.B. The thyroid and its disease. 4th Ed. (1975), John Wiley & Sons, Inc, New York
11. Cailleux A.F., Baudin E., Travagli G.P., Richard M., and Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab 85 (2000) 175-178
12. Pacini F., Capezzone M., Elisei R., Ceccarelli C., Taddei D., and Pinchera A. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87 (2002) 1499-1501
13. Simeone J.F., Daniels G.H., Hall D.A., McCarthy K., Kopans D.B., Butch R.J., et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148 (1987) 45-49
14. Franceschi M., Kusic Z., Franceschi D., Lukinac L., and Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37 (1996) 446-451
15. Schlumberger M., De Vathaire F., Travagli J.P., Vassal G., Lemerle J., Parmentier C., et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 65 (1987) 1088-1094
16. Antonelli A., Miccoli P., Derzhitski V.E., Panasiuk G., Solovieva N., and Baschieri L. Epidemiologic and clinical evaluation of thyroid cancer in children from the Gomel region (Belarus). World J Surg 20 (1996) 867-871
17. Miccoli P., Antonelli A., Spinelli C., Ferdeghini M., Fallahi P., and Baschieri L. Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 133 (1998) 89-93
18. Beasley N.J., Lee J., Eski S., Walfish P., Witterick I., and Freeman J.L. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128 (2002) 825-828
19. Hay I.D. Papillary Thyroid Carcinoma. Endocrinol Metab Clin North Am 19 (1990) 545-576
20. Frankenthaler R.A., Sellin R.V., Cangir A., and Goepfert H. Lymph node metastases from papillary-follicular thyroid carcinoma in young patients. Am J Surg 160 (1990) 341-343
21. Newman K.D., Black T., Heller G., Azizkhan R.G., Holcomb III G.W., Sklar C., et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 227 (1998) 533-541
22. Pineda J.D., Lee T., Ain K., Reynolds J.C., and Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80 (1995) 1488-1492
23. Pacini F., Agate L., Elisei R., Capezzone M., Ceccarelli G., Lippi F., et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131-I whole body scan: comparison of patients treated with high 131-I activities versus untreated patients. J Clin Endocrinol Metab 86 (2001) 4092-4097
24. Haughen B.R., Pacini F., Reiners C., Schlumberger M., Ladenson P.W., Sherman S.I., et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84 (1999) 3877-3888
25. Ceccarelli C., Battisti P., Gasperi M., Fantuzzi E., Pacini F., Gualdrini G., et al. Radiation dose to the testes after 131 I therapy for ablation of post surgical thyroid remnants in patients with differentiated thyroid cancer. J Nucl Med 40 (1999) 1716-1721